Strategic Initiative

Slingshot members are tracking this corporate initiative:

Renova Therapeutics Acquires IND Filing for Heart Failure Candidate Stesscopin from Janssen Pharmaceuticals (JNJ) for Undisclosed Amount

Source Link:
http://www.prnewswire.com/news-releases/renova-therapeutics-enters-into-agreement-to-receive-stresscopin-investigational-new-drug-file-from-janssen-300402057.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
Renova Therapeutics
100%
JNJ
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Strategic Initiative Date
Announcement Date:
Feb 06, 2017
Projected Implementation:
Q1, 2017
Relevance Tracked Until:
Q1, 2018
Related Projects Image

  • Don’t see a project related to the strategic initiative you care about?

Related Keywords Ind Filing, Stesscopin
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.